ACRVAcrivon Therapeutics, Inc. Common Stock

ACRV Stock Price, Valuation & Chart | Acrivon Therapeutics, Inc. Common Stock

Compare

$2.150+0.08 (+3.86%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ACRV intrinsic value ACRV calculated fair value vs price

Overview Financials Dividends Ratios

ACRV Historical price chart

ACRV Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization92.02M

PE Ratio-1.14

EPS-1.88

Trading Volume131.06K

Today's High/Low2.2/2.05

Dividend Yield0.00

52 Week High/Low3.56/1.27

Shares Outstanding42.80M

ACRV Financial Statement

ACRV Analyst ratings

ACRV Analysis & performance metrics

ACRV Company profile

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive…

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug…

ACRV Management team

Name

Position

Kristina Masson M.B.A., Ph.D.CTO

Co-Founder, Executive Vice President of Business Operations, Site Head, Treasurer & Director

Eric J. Devroe Ph.D.COO

Chief Operating Officer

Adam D. Levy M.B.A., Ph.D.CFO

Chief Financial Officer & Principal Financial Officer

Katharine Peterson CPA

Vice President of Finance & Accounting

Erick Gamelin M.D., Ph.D.

Chief Development Officer

Joon Jung Ph.D.

Vice President & Head of Data Science

Jesper V. Olsen Ph.D.

Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board

Peter Blume-Jensen M.D., Ph.D.CEO

Co-Founder, Chairman of the Board, Chief Executive Officer, President & Acting Chief Scientific Officer

Name

Position

Kristina Masson M.B.A., Ph.D.CTO

Co-Founder, Executive Vice President of Business Operations, Site Head, Treasurer & Director

Eric J. Devroe Ph.D.COO

Chief Operating Officer

Adam D. Levy M.B.A., Ph.D.CFO

Chief Financial Officer & Principal Financial Officer

Katharine Peterson CPA

Vice President of Finance & Accounting

Erick Gamelin M.D., Ph.D.

Chief Development Officer

Joon Jung Ph.D.

Vice President & Head of Data Science

Jesper V. Olsen Ph.D.

Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board

Peter Blume-Jensen M.D., Ph.D.CEO

Co-Founder, Chairman of the Board, Chief Executive Officer, President & Acting Chief Scientific Officer

Management Team

Kristina Masson M.B.A., Ph.D.CTO

Co-Founder, Executive Vice President of Business Operations, Site Head, Treasurer & Director

Eric J. Devroe Ph.D.COO

Chief Operating Officer

Adam D. Levy M.B.A., Ph.D.CFO

Chief Financial Officer & Principal Financial Officer

Katharine Peterson CPA

Vice President of Finance & Accounting

Erick Gamelin M.D., Ph.D.

Chief Development Officer

Joon Jung Ph.D.

Vice President & Head of Data Science

Jesper V. Olsen Ph.D.

Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board

Peter Blume-Jensen M.D., Ph.D.CEO

Co-Founder, Chairman of the Board, Chief Executive Officer, President & Acting Chief Scientific Officer

Management

Kristina Masson M.B.A., Ph.D.CTO

Co-Founder, Executive Vice President of Business Operations, Site Head, Treasurer & Director

Eric J. Devroe Ph.D.COO

Chief Operating Officer

Adam D. Levy M.B.A., Ph.D.CFO

Chief Financial Officer & Principal Financial Officer

Katharine Peterson CPA

Vice President of Finance & Accounting

Erick Gamelin M.D., Ph.D.

Chief Development Officer

Joon Jung Ph.D.

Vice President & Head of Data Science

Jesper V. Olsen Ph.D.

Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board

Peter Blume-Jensen M.D., Ph.D.CEO

Co-Founder, Chairman of the Board, Chief Executive Officer, President & Acting Chief Scientific Officer

Total 8 executives

ACRV Frequently asked questions

What is Acrivon Therapeutics, Inc. Common Stock (ACRV) Stock Price?

Current stock price of Acrivon Therapeutics, Inc. Common Stock (ACRV) stock is $2.150. The stock price is +3.86% higher in the session. The intraday range can be seen from this page. Volume of Acrivon Therapeutics, Inc. Common Stock (ACRV) stock is 131.06K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Acrivon Therapeutics, Inc. Common Stock (ACRV) stock price going up or down today?

The stock price of Acrivon Therapeutics, Inc. Common Stock (ACRV) can change with earnings, company news, and overall market sentiment. Acrivon Therapeutics, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Acrivon Therapeutics, Inc. Common Stock stock expensive at its current price?

Whether Acrivon Therapeutics, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ACRV on this page is -1.14. EPS on this page is -1.88. Compare those figures with peers and growth expectations before deciding if the current Acrivon Therapeutics, Inc. Common Stock price is justified.

How has the stock price of Acrivon Therapeutics, Inc. Common Stock (ACRV) performed historically?

Historical performance for Acrivon Therapeutics, Inc. Common Stock (ACRV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ACRV reacted to past earnings and market events.

Should I buy Acrivon Therapeutics, Inc. Common Stock (ACRV) stock, at this price?

Buying Acrivon Therapeutics, Inc. Common Stock (ACRV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.